We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+3.57%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$578B
AUM Growth
+$59.6B
Cap. Flow
+$35.2B
Cap. Flow %
6.08%
Top 10 Hldgs %
31.21%
Holding
15,826
New
1,745
Increased
6,428
Reduced
6,082
Closed
1,423

Top Buys

Rank Stock Value
1
BA icon
Boeing
BA
+$830M
2
UNH icon
UnitedHealth
UNH
+$769M
3
AJG icon
Arthur J. Gallagher & Co
AJG
+$691M
4
AMZN icon
Amazon
AMZN
+$654M
5
BAC icon
Bank of America
BAC
+$634M

Sector Composition

Rank Sector Weight
1 Healthcare 3.13%
2 Technology 2.97%
3 Financials 2.19%
4 Consumer Discretionary 2.09%
5 Industrials 1.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BPT
13801
PUT
DELISTED
BP Prudhoe Bay Royalty Trust
BPT
$5.77K ﹤0.01%
10,600
+2,300
+28% +$2.32K
BGSF icon
13802
CALL
BGSF Inc
BGSF
$60.4M
$5.76K ﹤0.01%
1,100
-400
-27% -$2.76K
THR
13803
CALL
DELISTED
Thermon Group Holdings
THR
$5.75K ﹤0.01%
+200
New +$5.89K
SVIIR
13804
DELISTED
Spring Valley Acquisition Corp II Rights
SVIIR
$5.73K ﹤0.01%
+81,500
New +$5.44K
NRXP icon
13805
PUT
NRX Pharmaceuticals
NRXP
$140M
$5.72K ﹤0.01%
2,600
+1,600
+160% +$2.15K
TXMD icon
13806
CALL
TherapeuticsMD
TXMD
$24M
$5.68K ﹤0.01%
6,600
+2,100
+47% +$2.96K
BSAC icon
13807
CALL
Banco Santander Chile
BSAC
$16.3B
$5.66K ﹤0.01%
300
-500
-63% -$9.77K
HCAT icon
13808
PUT
Health Catalyst
HCAT
$139M
$5.66K ﹤0.01%
800
-5,600
-88% -$44.6K
TBPH icon
13809
CALL
Theravance Biopharma
TBPH
$881M
$5.65K ﹤0.01%
600
+400
+200% +$3.64K
HOOK
13810
PUT
DELISTED
HOOKIPA Pharma
HOOK
$5.63K ﹤0.01%
2,800
+1,520
+119% +$4.7K
FOA icon
13811
PUT
Finance of America Companies
FOA
$201M
$5.62K ﹤0.01%
+200
New +$3.56K
FCUV icon
13812
CALL
Focus Universal
FCUV
$3.95M
$5.6K ﹤0.01%
40
+13
+48% +$1.33K
GLRE icon
13813
PUT
Greenlight Captial
GLRE
$514M
$5.6K ﹤0.01%
400
PHX
13814
PUT
DELISTED
PHX Minerals
PHX
$5.6K ﹤0.01%
1,400
-30,600
-96% -$112K
CLLS
13815
CALL
Cellectis
CLLS
$307M
$5.58K ﹤0.01%
3,100
-2,800
-47% -$5.22K
SPTI icon
13816
PUT
State Street SPDR Portfolio Intermediate Term Treasury ETF
SPTI
$10.6B
$5.58K ﹤0.01%
200
-600
-75% -$17K
BRX icon
13817
PUT
Brixmor Property Group
BRX
$9.2B
$5.57K ﹤0.01%
200
URE icon
13818
ProShares Ultra Real Estate
URE
$60.3M
$5.56K ﹤0.01%
89
-3,278
-97% -$232K
BBEU icon
13819
CALL
JPMorgan BetaBuilders Europe ETF
BBEU
$9.52B
$5.54K ﹤0.01%
+100
New +$5.86K
MPX
13820
PUT
DELISTED
Marine Products Corp
MPX
$5.5K ﹤0.01%
600
-2,000
-77% -$19.2K
EUFN icon
13821
iShares MSCI Europe Financials ETF
EUFN
$4.31B
$5.5K ﹤0.01%
+236
New +$5.65K
STKH
13822
CALL
Steakholder Foods
STKH
$2.13M
$5.47K ﹤0.01%
27
-8
-23% -$2.31K
FISI icon
13823
PUT
Financial Institutions
FISI
$823M
$5.46K ﹤0.01%
200
-100
-33% -$2.63K
NXDR
13824
PUT
Nextdoor Holdings
NXDR
$998M
$5.45K ﹤0.01%
2,300
-9,200
-80% -$22.8K
XSVM icon
13825
CALL
Invesco S&P SmallCap Value with Momentum ETF
XSVM
$677M
$5.45K ﹤0.01%
+100
New +$5.64K

Similar funds

Ken Griffin's Q4 2024 Portfolio in Review

As of Q4 2024, Ken Griffin held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Ken Griffin deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.

By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.

  • Ken Griffin's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
  • Ken Griffin added most to Boeing in Q4 2024, an estimated $830M increase.
  • Ken Griffin's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
  • Ken Griffin fully exited Spotify in Q4 2024, selling an estimated $473M.
  • Ken Griffin's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
  • Ken Griffin opened 1,745 new positions and closed 1,423 in Q4 2024.
  • Ken Griffin's portfolio value rose 11% quarter-over-quarter to $578B.

Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.